Status:

COMPLETED

A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The study is a double-blind, placebo-controlled, random-order, single-dose crossover trial of sildenafil 50 \& 100 mg added to stable antipsychotic treatment in schizophrenia patients to assess whethe...

Detailed Description

Specific Aims: 1. Evaluate the effects of single doses of sildenafil 50 \& 100 mg compared to placebo on cognitive functioning, including verbal memory, fluency, attention, spatial memory, motor spee...

Eligibility Criteria

Inclusion

  • Diagnosis of schizophrenia, any subtype.
  • Age 18-65 years
  • Male or female
  • Clinically stable without a medication change within 4 weeks
  • Able to complete cognitive testing (must be English-speaking)
  • Willing to use appropriate birth control during study participation (if female)

Exclusion

  • Active substance abuse or dependence
  • PDE 5 inhibitor taken within 24 hours of study drug
  • Currently taking a drug that inhibits hepatic cytochrome P450 3A4 (eg. Nefazadone, fluvoxamine, erythromycin, ketoconazole, itraconazole, cimetidine, saquinavir, ritonavir, St. John's wort, or grapefruit juice).
  • Currently taking drugs that induce P45 3A4 (eg. phenytoin, carbamezapine, Phenobarbital, rifampin)
  • Unstable medical disease
  • Significant cardiac disease
  • Bleeding disorder
  • Peptic ulcer disease
  • Hepatic impairment
  • Moderate or greater renal impairment
  • History of migraines
  • Currently taking nitrates or alpha blockers
  • Resting blood pressure \< 90/50 or \>140/90 mm.
  • History of intolerance to PDE5 inhibitors
  • History of inappropriate sexual behavior (eg, masturbation in public, stalking, assault)
  • History of priapism
  • Pregnant or lactating

Key Trial Info

Start Date :

February 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00455715

Start Date

February 1 2006

End Date

September 1 2008

Last Update

June 29 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114